Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 253

1.

Expression of proteasome subunit β5t in thymic epithelial tumors.

Yamada Y, Tomaru U, Ishizu A, Kiuchi T, Marukawa K, Matsuno Y, Kasahara M.

Am J Surg Pathol. 2011 Sep;35(9):1296-304. doi: 10.1097/PAS.0b013e3182237f5d.

PMID:
21836487
2.

Expression of thymoproteasome subunit β5t in type AB thymoma.

Yamada Y, Tomaru U, Ishizu A, Kiuchi T, Kasahara M, Matsuno Y.

J Clin Pathol. 2014 Mar;67(3):276-8. doi: 10.1136/jclinpath-2013-201930.

PMID:
24293611
3.

Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms.

Kojika M, Ishii G, Yoshida J, Nishimura M, Hishida T, Ota SJ, Murata Y, Nagai K, Ochiai A.

Mod Pathol. 2009 Oct;22(10):1341-50. doi: 10.1038/modpathol.2009.105.

4.
6.

Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma.

Pan CC, Chen PC, Chou TY, Chiang H.

Hum Pathol. 2003 Nov;34(11):1155-62.

PMID:
14652817
7.

Absence of gene mutations in KIT-positive thymic epithelial tumors.

Tsuchida M, Umezu H, Hashimoto T, Shinohara H, Koike T, Hosaka Y, Eimoto T, Hayashi JI.

Lung Cancer. 2008 Dec;62(3):321-5. doi: 10.1016/j.lungcan.2008.03.035.

PMID:
18486988
8.

Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma.

Hishima T, Fukayama M, Hayashi Y, Fujii T, Arai K, Shiozawa Y, Funata N, Koike M.

Hum Pathol. 1998 Apr;29(4):330-8.

PMID:
9563781
9.

Expression of apoptosis-related markers and HER-2/neu in thymic epithelial tumours.

Pan CC, Chen PC, Wang LS, Lee JY, Chiang H.

Histopathology. 2003 Aug;43(2):165-72.

PMID:
12877732
10.

Immunohistochemical differentiation between type B3 thymomas and thymic squamous cell carcinomas.

Su XY, Wang WY, Li JN, Liao DY, Wu WL, Li GD.

Int J Clin Exp Pathol. 2015 May 1;8(5):5354-62.

11.

Expression of neurotrophin receptors in surgically resected thymic epithelial tumors.

Kim DJ, Yang WI, Kim SH, Park IK, Chung KY.

Eur J Cardiothorac Surg. 2005 Oct;28(4):611-6.

PMID:
16125946
12.

MUC1 expression in thymic epithelial tumors: MUC1 may be useful marker as differential diagnosis between type B3 thymoma and thymic carcinoma.

Kaira K, Murakami H, Serizawa M, Koh Y, Abe M, Ohde Y, Takahashi T, Kondo H, Nakajima T, Yamamoto N.

Virchows Arch. 2011 May;458(5):615-20. doi: 10.1007/s00428-011-1041-x.

PMID:
21253760
14.

Glut-1 intensity and pattern of expression in thymic epithelial tumors are predictive of WHO subtypes.

Thomas de Montpréville V, Quilhot P, Chalabreysse L, De Muret A, Hofman V, Lantuéjoul S, Parrens M, Payan MJ, Rouquette I, Secq V, Girard N, Besse B, Marx A, Molina TJ.

Pathol Res Pract. 2015 Dec;211(12):996-1002. doi: 10.1016/j.prp.2015.10.005.

PMID:
26534878
15.

Exclusive expression of proteasome subunit {beta}5t in the human thymic cortex.

Tomaru U, Ishizu A, Murata S, Miyatake Y, Suzuki S, Takahashi S, Kazamaki T, Ohara J, Baba T, Iwasaki S, Fugo K, Otsuka N, Tanaka K, Kasahara M.

Blood. 2009 May 21;113(21):5186-91. doi: 10.1182/blood-2008-11-187633.

16.

ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting.

Marx A, Ströbel P, Badve SS, Chalabreysse L, Chan JK, Chen G, de Leval L, Detterbeck F, Girard N, Huang J, Kurrer MO, Lauriola L, Marino M, Matsuno Y, Molina TJ, Mukai K, Nicholson AG, Nonaka D, Rieker R, Rosai J, Ruffini E, Travis WD.

J Thorac Oncol. 2014 May;9(5):596-611. doi: 10.1097/JTO.0000000000000154.

17.

Proteasome subunit β5t expression in cervical ectopic thymoma.

Tomaru U, Yamada Y, Ishizu A, Kuroda T, Matsuno Y, Kasahara M.

J Clin Pathol. 2012 Sep;65(9):858-9. doi: 10.1136/jclinpath-2012-200820. No abstract available.

PMID:
22523338
18.

Proliferative activity and apoptosis in thymic epithelial neoplasms.

Hiroshima K, Iyoda A, Toyozaki T, Supriatna Y, Shibuya K, Shimamura F, Haga Y, Yoshida S, Fujisawa T, Ohwada H.

Mod Pathol. 2002 Dec;15(12):1326-32.

19.

Immunoreactivity of a new CD5 antibody with normal epithelium and malignant tumors including thymic carcinoma.

Tateyama H, Eimoto T, Tada T, Hattori H, Murase T, Takino H.

Am J Clin Pathol. 1999 Feb;111(2):235-40.

PMID:
9930146
20.

Immunohistochemical KIT (CD117) expression in thymic epithelial tumors.

Nakagawa K, Matsuno Y, Kunitoh H, Maeshima A, Asamura H, Tsuchiya R.

Chest. 2005 Jul;128(1):140-4.

PMID:
16002927

Supplemental Content

Support Center